CEO Perspectives on Launching & Growing Biotech Start-Ups Webinar

Have you developed a cancer technology and are now looking to take the next steps to move it from lab to market? Lu Alleruzzo, M.B.A., has walked this path when granted an opportunity to commercialize his innovation early on in his career. He is now the CEO, co-founder, and board member of Immunophotonics, a clinical-stage biotech company developing an interventional immuno-oncology product. To date, the company has secured more than $40M in funding and is preparing a Phase II/III clinical trial program in collaboration with the Cardiovascular and Interventional Radiological Society of Europe, a leading interventional oncology medical society.

Join NCI's SBIR Development Center on Tuesday, November 19, for the next NCI SBIR Peer Learning and Networking (PLAN) webinar featuring Mr. Alleruzzo as he walks through his experiences in launching and growing biotech start-ups. 

This discussion will cover:

• Company launch
• Maintaining runway
• Strategic vision
• Milestone setting
• Investor fundraising

Visit the NCI SBIR PLAN webinar series for more best practices from SBIR standout companies that have achieved success in product development and technological commercialization. For more information, contact NCI SBIR Program Director William Bozza at [email protected].